Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120347) titled 'A Study on Rapid Second-Line Switching Strategies for HIV-Infected Individuals Following First-Line Treatment Failure' on March 12.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Second Hospital of Nanjing
Condition:
HIV drug resistance
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-27
Target Sample Size: Quick Launch Group:110;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306102
Published by HT Digital Content Services with permission from Health Daily Digest....